Indoco Remedies Share Price

Indoco Remedies

CMP as on 18-Jan-22 15:57

₹ 429.05
-8.90 -2.03%

Open

₹ 439.95

Turnover (lac)

₹ 236

Prev. Close

₹ 437.95

Day's Vol (shares)

₹ 55,018

Day's Range (₹)

₹ 427.65
₹ 441.85

CMP as on18-Jan-22 15:37

₹ 429.15
-9.15 -2.09%

Open

₹ 438.95

Turnover (lac)

₹ 19

Prev. Close

₹ 438.30

Day's Vol (shares)

₹ 7,241

Day's Range

₹ 426.95
₹ 441.35

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 11-Oct-2021 - -
Quarterly Results Submission of Standalone and Consolidated Financial Results as on 30th September 2021 (As Per BSE Announcement Dated 02.11.2021)
Board Meeting - 13-Jul-2021 - -
INDOCO REMEDIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2021 ,inter alia, to consider and approve Unaudited Financial Results for the quarter ended June 30, 2021 UNAUDITED FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED 30.06.2021 (As Per BSE Announcement Dated on 11.08.2021)
Board Meeting - 03-May-2021 - -
INDOCO REMEDIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2021 ,inter alia, to consider and approve Audited Financial Results for the year ended 31.03,2021 & Recommendation of Dividend if any, for the financial year 2020-21 Indoco Remedies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 25, 2021, inter alia, has recommended dividend of Rs. 1.50/- per share (75%) on face value of Rs. 2/- each for the financial year 2020-2021, subject to the Members approval at the AGM. Audited Standalone Financial Results of the Company, as per the IND AS for the quarter and year ended 31st March,2021 Audited Consolidated Financial Results of the Company, as per the IND AS for the year ended 31st March, 2021 (As Per BSE Announcement Dated on 5/25/2021)
Board Meeting - 13-Jan-2021 - -
INDOCO REMEDIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2021 ,inter alia, to consider and approve Unaudited Financial Results for the quarter ended December, 31, 2020 Unaudited financial results for the quarter ended 31.12.2020 (AS Per BSE Announcement Dated on 09.02.2021)
Open ZERO Brokerage Demat Account Open ZERO Brokerage Demat Account

  • 0

    Delivery Brokerage for Lifetime

  • 20

    Per order for Intraday, F&O, Currency & Commodity